November 12th 2024
A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
FDA panel recommends Sculptra to treat HIV-related lipoatrophy
April 1st 2004Gaithersburg, Md. - The FDA General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee meeting on March 25 unanimously recommended approval of Sculptra for reconstructive purposes with lipoatrophy associated with HIV infection and treatment. However, because of limited clinical data and fear of off-label use, the panel recommended attaching five conditions to that approval.
Maggot debridement therapy promising
March 1st 2004Akron, Ohio - Maggot debridement therapy (MDT), a controversial, but reportedly effective wound-healing technique, has attracted a following abroad in recent years, and is now gaining interest in the United States, as well. MDT is the medical use of live maggots or fly larvae for cleaning non-healing wounds. "MDT has been around for centuries -- so it's certainly not new, but there has been a resurgence of interest," said dermatologist and wound-care specialist Elliot N. Mostow, M.D., of Wound Care Associates of Akron (Ohio).
Stem cells proliferate, regenerate
March 1st 2004National report -- In a study that could have implications for faster wound healing in the future, Australian researchers have dispelled the belief that only epidermal stem cells are capable of tissue regeneration; short term and long term. They report in the February 2004 issue of The Journal of Clinical Investigation that significant proliferative and tissue-regenerative capacity resides in the more mature progeny of keratinocyte stem cells - including early differentiating cells.
Topical bexarotene benefits mycosis fungoides
March 1st 2004Waikoloa, Hawaii - Bexarotene 1 percent gel (Targretin) is a useful alternative modality, offering advantages to other therapies, for the treatment of mycosis fungoides (MF), according to Joan Guitart, M.D., at the annual Hawaii Dermatology Seminar in January.
Slew of new fillers requires keen attention to technique
March 1st 2004Waikoloa, Hawaii - Nearly two decades after bovine collagen hit the market, several new allergy-free, long-lasting dermal fillers are available for soft tissue augmentation. "Every new filler is a step closer to perfection with no reactivity and good longevity for filling wrinkles and folds," said Mark G. Rubin, M.D., at the annual Hawaii Dermatology Seminar.
Bioengineered skin improves pediatric wound healing
March 1st 2004Miami, Fla. - Dermatologists face extraordinary difficulties in their efforts to heal the wounds of epidermolysis bullosa (EB) patients because of the genetic absence of anchoring structures, such as anchoring fibrils and hemidesmosomes. While there has been significant progress in the science of identifying the structural defects and genetic sites of damage that lead to this disease, wound healing remains a great challenge, according to Lawrence Schachner, M.D., professor of dermatology, professor of pediatrics and interim chair at the University of Miami School of Medicine, Miami, Fla.
Sugars studied for anti-aging benefits
March 1st 2004Washington - New N-Acetylamino (N-A) sugars are building a data trail in order to square off with acids for space in moisturizing creams and other anti-aging products. Said Barbara Green R.Ph., director of technical and consumer affairs for NeoStrata Company, Inc., "N-Acetyl offers a new therapeutic skin care alternative with anti-aging benefits, specifically improved for skin plumping and thickness."
Dermal filler options keep growing
February 9th 2004Recent regulatory decisions about hyaluronic acids and hyaluronic gelshave brought facial wrinkle fillers even further into the fold of the impulsepurchase. "This changes everything," said Florida and New Yorkdermatolgist and filler expert Frederic S. Brandt, M.D., "because thesefillers don't require skin testing, which means that as soon someone comesin, they can get treatment."
Organizing the topical antiaging product shelf
February 9th 2004Dermatologists and their patients have numerous cosmeceutical productsfrom which to choose. Doctors who categorize the agents can better helptheir patients understand how the novel therapies fit into skincare regimens.According to Zoe Diana Draelos, M.D., clinical associate professor ofdermatology, Wake Forest University School of Medicine, Winston Salem, N.C.,key cosmeceutical categories include: barrier-enhancing vitamins, receptor-mediatedvitamins, regulators of collagen breakdown, anti-inflammatories, exfoliates,and botanicals.
Botulinum toxin has long-lasting effect in the treatment of hyperhidrosis
February 9th 2004February 10 - Intradermal botulinum toxin has a durable effect in thetreatment of primary axillary hyperhidrosis, with nearly half of treatmentresponders requiring only one injection over a 52-week period, said DeeAnna Glaser, M.D., associate professor, department of dermatology, St. LouisUniversity.
Botox complications rare, but possible
February 8th 2004As dermatologists accumulate knowledge about the injection of botulinumtoxin Type A, the safer the procedure is becoming, according to AlastairCarruthers, M.D.With reports of rare side effects, such as extreme fatigue and headaches,surfacing from sources across the United States, dermatologists might bequestioning the safety of a drug that continues to grow in popularity anddemand. But these concerns should be eased with sound evidence supportingthe contrary.
Volumetric facial rejuvenation using implants restores youthful appearance
February 8th 2004Experts in the art of facial rejuvenation are now able to restore orenhance the "pillars" of the face - chins, cheekbones, and jawlines - for many patients who have lost the strength of these characteristicsat midlife. As a result, more and more patients are enjoying the permanentyet reversible changes that can be made to the face using a variety of volumetricimplants.
Putting sunscreens in their place
February 7th 2004When it comes to photoprotection, people expect too much from sunscreens.In a perfect world - if people would put on enough to get full protection,reapply it as often as necessary, use a high enough SPF and a sunscreenwith the best protective ingredients, and start early enough in life protectingtheir skin from the sun - sunscreens might offer powerful protection againstmalignant melanoma and other skin conditions related to the sun. However,ours is not a perfect world and dermatologists should arm patients withthe reality that sunscreens alone are not the end-all solution in sun protection.
CO2 laser still 'gold standard' for tissue tightening
February 6th 2004Despite the growing popularity of new modalities, the CO2 laser remainsthe gold standard for tissue tightening and contraction of the skin, saidSue Ellen Cox, M.D. However, the choice of therapy largely depends on theage and mindset of the patient, she added.
Where will modern acne treatment take us?
February 1st 2004Laser and light therapies, while still controversial, are dramatically changing acne treatment. Rosacea patients also benefit from the more patient-friendly nondrug options. And drug therapies, including hormonal options, provide a strong hope that patients will have alternatives in treatment aimed at tackling severe acne in the future.
Isotretinoin, retinoids key evolution
February 1st 2004Many of the modern therapies that evolved during the last 25 years are new, more patient-friendly twists on old therapies. Harsh treatments with unpleasant odors that fail to diminish the most severe forms of acne and rosacea are no longer the main tools in the dermatologists' arsenal.